Valisure announced new substantial investments from leading healthcare venture capital firms led by AlleyCorp, a New York-based venture capital firm. This strategic investment is a significant milestone for Valisure, providing the financial resources needed to accelerate research and development, expand our team of experts, and solidify our position as a market leader in independent pharmaceutical quality assurance.

In addition to this exciting news, we are delighted to introduce Chip Phillips as our new Chief Executive Officer. His leadership will be instrumental in guiding Valisure as we navigate challenges in the industry, including supply chain concerns, drug shortages, and quality issues.With Chip's appointment, our Co-Founder David Light assumes the role of President, focusing on expanding Valisure's thought leadership and mission through our extensive network of government, industry, and academic partners.

In addition, we are excited to announce Wolfgang Hinz as our Chief Scientific Officer, Adam Clark-Joseph as Chief Analytics Officer, and Jill Nailor, RPh, who assumes the Chief Business Development Officer role.

Read the full article via Hartford Business Journal.

Valisure announced new substantial investments from leading healthcare venture capital firms led by AlleyCorp, a New York-based venture capital firm. This strategic investment is a significant milestone for Valisure, providing the financial resources needed to accelerate research and development, expand our team of experts, and solidify our position as a market leader in independent pharmaceutical quality assurance.

In addition to this exciting news, we are delighted to introduce Chip Phillips as our new Chief Executive Officer. His leadership will be instrumental in guiding Valisure as we navigate challenges in the industry, including supply chain concerns, drug shortages, and quality issues.With Chip's appointment, our Co-Founder David Light assumes the role of President, focusing on expanding Valisure's thought leadership and mission through our extensive network of government, industry, and academic partners.

In addition, we are excited to announce Wolfgang Hinz as our Chief Scientific Officer, Adam Clark-Joseph as Chief Analytics Officer, and Jill Nailor, RPh, who assumes the Chief Business Development Officer role.

Read the full article via Hartford Business Journal.